Form 4: Solenis Therapeutics Inc. Executive Michael F. Huang Reports Changes in Beneficial Ownership
SEC Form 4
Michael F. Huang, Sr. VP of Clinical Development at Soleno Therapeutics Inc., reports acquisition of common stock and stock options.
Summary
- Michael F. Huang, a Senior VP at Soleno Therapeutics Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- On January 21, 2025, Huang acquired 6,400 shares of common stock and 13,800 employee stock options.
- The common stock was acquired at a price of $0.
- The exercise price for the stock options is $49.17.
- Following these transactions, Huang beneficially owns 41,400 shares of common stock and 13,800 derivative securities (employee stock options).
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Positives
- The acquisition of shares and options by a company executive can be seen as a positive sign, indicating confidence in the company's future prospects.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedules for the RSUs and stock options suggest a continued employment relationship between the reporting person and the issuer.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the ownership stake of a key executive.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of transaction: Acquisition of common stock and employee stock options. |
| 12/15/2024 | Start date for annual vesting of 1/4th of the restricted stock units. |
| 02/01/2025 | Start date for monthly vesting of 1/48th of the employee stock options. |
| 01/21/2035 | Expiration date of the employee stock options. |
| 01/23/2025 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.